These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1936 related items for PubMed ID: 7726138

  • 1. KP1/CD68 expression in malignant neoplasms including lymphomas, sarcomas, and carcinomas.
    Gloghini A, Rizzo A, Zanette I, Canal B, Rupolo G, Bassi P, Carbone A.
    Am J Clin Pathol; 1995 Apr; 103(4):425-31. PubMed ID: 7726138
    [Abstract] [Full Text] [Related]

  • 2. KP1 (CD68)-positive large cell lymphomas: a histopathologic and immunophenotypic characterization of 12 cases.
    Carbone A, Gloghini A, Volpe R, Pinto A.
    Hum Pathol; 1993 Aug; 24(8):886-96. PubMed ID: 7690736
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A, Gloghini A, Volpe R.
    Cancer; 1992 Dec 01; 70(11):2691-8. PubMed ID: 1330287
    [Abstract] [Full Text] [Related]

  • 4. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.
    Falini B, Flenghi L, Pileri S, Gambacorta M, Bigerna B, Durkop H, Eitelbach F, Thiele J, Pacini R, Cavaliere A.
    Am J Pathol; 1993 May 01; 142(5):1359-72. PubMed ID: 7684194
    [Abstract] [Full Text] [Related]

  • 5. CD68 reactivity of non-macrophage derived tumours in cytological specimens.
    Doussis IA, Gatter KC, Mason DY.
    J Clin Pathol; 1993 Apr 01; 46(4):334-6. PubMed ID: 7684403
    [Abstract] [Full Text] [Related]

  • 6. Expression of the monomeric 67-kd laminin-binding protein in human lymphomas as defined by MLuC5 monoclonal antibody and paraffin section immunohistochemistry.
    Carbone A, Gloghini A, Colombatti A, Castronovo V, Ménard S.
    Hum Pathol; 1995 May 01; 26(5):541-6. PubMed ID: 7750938
    [Abstract] [Full Text] [Related]

  • 7. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M.
    Arch Pathol Lab Med; 1992 Nov 01; 116(11):1197-201. PubMed ID: 1332642
    [Abstract] [Full Text] [Related]

  • 8. Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry.
    Kunisch E, Fuhrmann R, Roth A, Winter R, Lungershausen W, Kinne RW.
    Ann Rheum Dis; 2004 Jul 01; 63(7):774-84. PubMed ID: 15194571
    [Abstract] [Full Text] [Related]

  • 9. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS, Singleton TP, Weiss SW.
    Mod Pathol; 1997 May 01; 10(5):438-42. PubMed ID: 9160307
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.
    Warnke RA, Pulford KA, Pallesen G, Ralfkiaer E, Brown DC, Gatter KC, Mason DY.
    Am J Pathol; 1989 Dec 01; 135(6):1089-95. PubMed ID: 2688430
    [Abstract] [Full Text] [Related]

  • 11. KP1 (CD68) expression in benign neural tumours. Further evidence of its low specificity as a histiocytic/myeloid marker.
    Dei Tos AP, Doglioni C, Laurino L, Fletcher CD.
    Histopathology; 1993 Aug 01; 23(2):185-7. PubMed ID: 8406391
    [No Abstract] [Full Text] [Related]

  • 12. Detection of interstitial increase in macrophages, characteristic of acute interstitial rejection, in routinely processed renal allograft biopsies using the monoclonal antibody KP1.
    Dooper IM, Bogman MJ, Hoitsma AJ, Maass CN, Assmann KJ, Koene RA.
    Transpl Int; 1992 Sep 01; 5(4):209-13. PubMed ID: 1384532
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of Epstein-Barr viral genomes by in situ hybridization in acquired immune deficiency syndrome-related high grade and anaplastic large cell CD30+ lymphomas.
    Carbone A, Gloghini A, Zanette I, Canal B, Volpe R.
    Am J Clin Pathol; 1993 Mar 01; 99(3):289-97. PubMed ID: 8383422
    [Abstract] [Full Text] [Related]

  • 14. KP-1: not a specific marker. Staining of 137 sarcomas, 48 lymphomas, 28 carcinomas, 7 malignant melanomas and 8 cystosarcoma phyllodes.
    Cassidy M, Loftus B, Whelan A, Sabt B, Hickey D, Henry K, Leader M.
    Virchows Arch; 1994 Mar 01; 424(6):635-40. PubMed ID: 7519954
    [Abstract] [Full Text] [Related]

  • 15. Aberrant expression of macrophage-associated antigens (CD68 and Ki-M1P) by Schwann cells in reactive and neoplastic neural tissue. Light- and electron-microscopic findings.
    Kaiserling E, Xiao JC, Ruck P, Horny HP.
    Mod Pathol; 1993 Jul 01; 6(4):463-8. PubMed ID: 8415593
    [Abstract] [Full Text] [Related]

  • 16. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS, Nadler LM.
    Hematol Oncol Clin North Am; 1991 Oct 01; 5(5):871-89. PubMed ID: 1938759
    [Abstract] [Full Text] [Related]

  • 17. A histiocyte-specific marker in the diagnosis of malignant fibrous histiocytoma. Use of monoclonal antibody KP-1 (CD68).
    Binder SW, Said JW, Shintaku IP, Pinkus GS.
    Am J Clin Pathol; 1992 Jun 01; 97(6):759-63. PubMed ID: 1317667
    [Abstract] [Full Text] [Related]

  • 18. Malignant hematopoietic breast tumors.
    Lin Y, Govindan R, Hess JL.
    Am J Clin Pathol; 1997 Feb 01; 107(2):177-86. PubMed ID: 9024066
    [Abstract] [Full Text] [Related]

  • 19. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L, Del Vecchio MT, Kraft R, Megha T, Barbini P, Cevenini G, Poggi S, Pileri S, Tosi P, Cottier H.
    Am J Pathol; 1990 Nov 01; 137(5):1047-57. PubMed ID: 2173409
    [Abstract] [Full Text] [Related]

  • 20. CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas.
    Wobser M, Roth S, Reinartz T, Rosenwald A, Goebeler M, Geissinger E.
    Br J Dermatol; 2015 Jun 01; 172(6):1573-1580. PubMed ID: 25524664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.